Progreso Quercus Competitors

Greenfield Partners was established by Eugene A. ("Gene") Gorab in 1997, and has since become one of the leading real estate investment managers in North America. Our firm manages capital on behalf of its Principals and Limited Partners and has, since inception, secured capital commitments in excess of $4.0 billion across a series of discretionary investment vehicles. Our Limited Partners include leading state and corporate pension plans, university endowments, private foundations and high net worth individuals. Greenfield is based in southwestern Connecticut with additional offices in Chicago, IL, and Arlington, VA. Our senior investment team averages 25 years of experience and our capabilities also encompass the related disciplines of development, tax, and finance. Our long-standing relationships provide a deep network of operating partners to draw upon such as property type experts and regionally focused sharpshooters. While, as a firm, we place tremendous emphasis on direct investment control, these partners expand our reach and allow us to better leverage the time and talent of our Principals.

Agriwise Finserv Limited (erstwhile StarAgri Finance Limited) is an SI-NBFC registered with the RBI and one of India’s leading agri finance companies. We provide credit to small farmers, FPOs, input distributors & retailers, agri infrastructure or equipment providers, contract farmers, or any value-generating participant in the agri value chain. We have partnered with over 50 banks and financial institutions to help farming communities get easy access to capital. This empowers them to improve farm activities and realize better value for their produce. Our deep knowledge of rural India and acknowledging that farmers need more than just loans gives Agriwise an advantage over other lenders. Besides providing credit, we share our expertise in marrying technology with farming to help them unlock new revenue streams. We believe finance should be an enabler and not a burden or a liability. Being agripreneurs ourselves, we understand the unique challenges of farmers. Securing finance can often become a daunting task, given the complexities in the process. Agriwise makes agri-finance simpler, easier and faster. A three-step application process and 24-hour approvals ensure access to finance is never a barrier in a progressive farmer’s growth. We combine traditional agri-knowledge with transparent credit and tech-driven insights to help farmers and agri & allied businesses realize more value from the credit they secure. We aim to empower the agri-ecosystem by building value through credit financing. We see a future where new-age technology coupled with age-old wisdom can drive efficiency in the agriculture sector, benefitting every participant in the value chain.

BioHarvest Sciences Inc. (Nasdaq: BHST) is a public biotech company that has developed a patented Botanical Synthesis platform technology capable of growing the active and beneficial compounds in fruit & plants, at an industrial scale, without the need to grow the plant itself. BioHarvest has invested 17 years and >$100M to develop our Botanical Synthesis Technology, which produces unique and patentable botanical compositions which contain a “target optimized” combination of the phyto-medicinal compounds (with high solubility and bio-availability) found in the original plant. No other company has developed a commercially viable plant cell culture platform at the industrial scale of BioHarvest. BioHarvest is focused on leveraging this platform technology across the following business units: 1. Biologics+ CDMO Services: BioHarvest is leveraging its Botanical Synthesis technology to allow global pharmaceutical, nutrition, cosmetics, and nutraceutical partners to develop proprietary compounds with unmatched predictability and consistency, manufactured at industrial scale under exclusive partnerships. 2. Direct to Consumer Business Anchored in Science: BioHarvest has built its own direct to consumer business of propriety botanical compositions. The first product, VINIA® was launched into the US in 2021 and has now exceeded 60,000 daily users (>$50M USD Revenue since 2021 launch). VINIA® contains multiple polyphenols, including Piceid Resveratrol, with an amount in each daily 400mg capsule that is equivalent to 1,000 grapes, resulting in a powerful nutraceutical that has been clinically proven (in a published double-blind placebo-controlled study), to significantly increase dilation of arteries. This increased dilation of arteries improves blood flow and the delivery of oxygen and nutrients to the body, tissue & organs.